(Q45235961)

11 December 2017

title

Treatment of Graves' disease and the course of ophthalmopathy (English)

1 reference

11 December 2017

1 reference

Sridama V

1

1 reference

11 December 2017

DeGroot LJ

series ordinal

2

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

American Journal of Medicine

11 December 2017

published in

1 reference

11 December 2017

volume

87

1 reference

11 December 2017

issue

1

1 reference

11 December 2017

page(s)

70-73

1 reference

MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Long-Term Follow-up Study of Compensated Low-Dose131I Therapy for Graves' Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Appearance of unilateral infiltrative exophthalmos of Graves' disease after the successful treatment of the same process in the contralateral eye by apparently total surgical hypophysectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Pituitary Secretion of Free Alpha and Beta Subunit of Human Thyrotropin in Patients with Thyroid Disorders1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Effects of antithyroid drugs on lymphocyte function in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Carbimazole and the Autoimmune Response in Graves' Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Inhibition of Immunoglobulin-Secreting Cells by Antithyroid Drugs*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Studies on the pathogenesis of the ophthalmopathy of Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

THYROID BINDING ANTIBODIES AND OTHER IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WITH GRAVES’OPHTHALMOPATHY: EFFECT OF TREATMENT WITH CYCLOPHOSPHAMIDE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

The course of endocrine ophthalmopathy during antithyroid therapy in a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980485-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(89)80485-1

1 reference

11 December 2017

1 reference